Latest News about Psychedelic/Assisted Therapies

Recent news which mentions Psychedelic/Assisted Therapies

...

8 9 10 11 12 13 14 15 Next >

Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal

May 11, 2023

Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials

May 11, 2023

Promising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completed

May 10, 2023

Stress-Related Mood Disorders And Alzheimer's: Can This Patented Ketamine Drug Help?

May 10, 2023

Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released

May 09, 2023

Legal Magic Mushroom Therapy Now Available In Oregon, But Are Prices Too Steep?

May 09, 2023

Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist

May 08, 2023

Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More

May 08, 2023

Phase 2 Psilocybin Therapy Trial For Patients With Treatment-Resistant PTSD: Latest Findings

May 07, 2023

Oregon Certifies First Psychedelics-Assisted Therapy Center In The Nation

May 05, 2023

MindMed Reports Q1 2023 Financial Results, Business Highlights, Upcoming Elections

May 05, 2023

NY Biotech Gets International IP Coverage For Growing Portfolio Of Psychedelic-Derived Novel Drugs

May 05, 2023

Washington State County Decriminalizes Psychedelics, Gov. Calls For Special Session On Drug Policy

May 04, 2023

International IP Claims On Novel Psychedelic Fungi Biomass Manufacturing Gets Prelim Acceptance

May 03, 2023

Colorado's Rapidly-Progressing Measure For Legal Psychedelics Regulation Heads To Gov.'s Desk

May 03, 2023

Next-Gen Israeli Psychedelics Company Gears Up For Trial Targeting Alcohol Addiction

May 03, 2023

Psychedelics Reform Update: Arizona's MDMA Gets Gov's Signature, California, Minnesota & Missouri's Progress

May 02, 2023

EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations

May 02, 2023

EXCLUSIVE: Ibogaine Therapy Co. Bienstar On Successful Addiction Treatment, Global Market & Future Prospects

April 27, 2023

Colorado Takes Another Step In Psychedelics Regulation As Amended Bill Receives Approval

April 26, 2023

Oregon Pioneers Legal Psilocybin Therapy, But This Type Of License Has Yet To Be Issued

April 26, 2023

This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection

April 26, 2023

Reunion Neuroscience Enters Compliance Period, Struggles To Remain NASDAQ Listed

April 25, 2023

New Set Of MDMA Analogs To Hit The Clinic: These Are The Latest Positive Findings

April 25, 2023

Can AI Foster Research And Psychedelics Therapy Without Replacing Human Connection?

April 24, 2023

Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More

April 24, 2023

Psychedelics Reform Update: NC's $5M Grant, WA's Pilot Program, Plus Rescheduling Proposals

April 21, 2023

Psychedelics Therapy For Teens, Elders, And Borderline Disorder Patients: Here Are The Latest Findings

April 21, 2023

Psyched Clinical Trials: Australian Univ. Pursues MDMA, MEAI Compound About To Set Off

April 20, 2023

Psyched Business: Lobe Buys Rare Disease Treatment, Plus Healing CREI And Heally Team Up

April 20, 2023

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.